行情

TFX

TFX

泰利福
NYSE

实时行情|Nasdaq Last Sale

395.14
+7.38
+1.90%
已收盘, 16:12 02/19 EST
开盘
389.42
昨收
387.76
最高
398.65
最低
386.34
成交量
28.81万
成交额
--
52周最高
398.65
52周最低
269.88
市值
182.87亿
市盈率(TTM)
42.10
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TFX 新闻

  • Teleflex Sees FY20 Adj. EPS $12.50-$12.70 vs $12.68 Estimate, GAAP Sales Growth 6.5-7.5% Year Over Year
  • Benzinga.40分钟前
  • Teleflex Q4 EPS $3.28 Beats $3.22 Estimate, Sales $680.952M Beat $679M Estimate
  • Benzinga.41分钟前
  • Earnings Scheduled For February 20, 2020
  • Benzinga.3小时前
  • Teleflex Q4 2019 Earnings Preview
  • Seeking Alpha - Article.13小时前

更多

所属板块

医疗设备、用品及经销
+0.68%
医疗设备和用品
+0.76%

热门股票

名称
价格
涨跌幅

TFX 简况

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.
展开

Webull提供Teleflex Incorporated的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。